Development Risk Assessment Tool for Hepatitis B and C Virus Infections for People in Health Region 7

Authors

  • Pissamai Surakan The Office of Disease Prevention and Control 7 Khon Kaen, Department of Disease Control
  • Pranatthapong Kabkrathok Sirindhorn College of Public Health Phitsanulok, Faculty of Public Health and Allied Health Sciences, Praboromarajchanok Institute
  • Nuttaporn Leenwiphat The Office of Disease Prevention and Control 7 Khon Kaen, Department of Disease Control
  • Piyathida Phutachai Khon Kaen Provincial Administrative Organization, Department of local Administration
  • Thanade Nonsrirach The Office of Disease Prevention and Control 7 Khon Kaen, Department of Disease Control

DOI:

https://doi.org/10.14456/dcj.2025.61

Keywords:

Risk Assessment Tool, Hepatitis B virus, Hepatitis C virus

Abstract

This research aimed to develop a risk assessment tool for hepatitis B and C infections to support disease prevention and control efforts. The research involved three stages: firstly, developing instrument; secondly, testing; and finally, usability assessment. The study samples included individuals aged 30 years and older who lived in the areas of local administrative organizations within Health Region 7. Qualitative data were analyzed using content analysis and quantitative data using descriptive and inferential statistics. The developed assessment tool contained 12 questions related to risks for hepatitis B and C infections, and 12 questions designed to assess the participants’ knowledge and understanding of the diseases. The Item-Objective Congruence (IOC) values ranged from 0.67 to 1.00, and the KR-20 reliability coefficient of an assessment tool was 0.84. For hepatitis B infection prediction, the area under the ROC curve was 69.33% (95% CI: 0.60-0.80), with a sensitivity of 68.00% (95% CI: 65.42-70.61), specificity of 66.30% (95% CI: 63.63-68.92), and accuracy of 66.30%. For hepatitis C prediction, the ROC curve was 60.20% (95% CI: 0.80-1.00), with a sensitivity of 75.40% (95% CI: 74.33-6.64), specificity of 41.50% (95% CI: 40.11-42.82), and accuracy of 41.80%. In addition, the developed risk assessment tool demonstrated acceptable validity and reliability and was rated highly satisfactory by users, with an average satisfaction score of 4.34 (SD=0.76).

Downloads

Download data is not yet available.

References

Department of Disease Control (TH), Division of AIDS and STIs. Thailand National Strategies to Eliminate Viral Hepatitis 2022-2030. Nonthaburi: Department of Disease Control; 2023. (in Thai)

Department of Disease Control (TH), Division of AIDS and STIs. National Guideline on Elimination of Viral Hepatitis B&C and Elimination of Mother-to-child Transmission of Hepatitis B Virus 2023. Nonthaburi: Department of Disease Control; 2023. (in Thai)

Department of Disease Control (TH), Division of AIDS and STIs. Guidelines for screening and treatment of chronic hepatitis B to improve access to antiviral therapy. Nonthaburi: Department of Disease Control; 2022. (in Thai)

Department of Disease Control (TH), Division of AIDS and STIs. Operational guidelines for screening hepatitis B and C infections among at-risk target populations, with referral to treatment systems within local administrative areas. Nonthaburi: Department of Disease Control; 2023. (in Thai)

Surakan S, Leenwiphat N, Phutachai P, Uthruk K, Paladchai P. Results of the development of the hepatitis C prevention and control system in Kalasin Provincial Prison. Thai AIDS Journal. 2023;35(3):140-50. (in Thai)

Ministry of Public Health (TH). Guidelines for the Screening and Treatment of Hepatitis B and C for General Practitioners 2024. Nonthaburi: Ministry of Public Health; 2024. (in Thai)

Kanjanawasee S. Classical Test Theory. 7th ed. Bangkok: Chulalongkorn University; 2013. (in Thai)

Kuder GF, Richardson MW. The theory of the estimation of test reliability. Psychometrika 1937;2(3):151-60.

Hebo HJ, Gemeda DH, Abdusemed KA. Hepatitis B and C Viral Infection: Prevalence, Knowledge, Attitude, Practice, and Occupational Exposure among Healthcare Workers of Jimma University Medical Center, Southwest Ethiopia. Sci World J. 2019;9482607:1-11.

Namwong T, Nithikathkul C, Promsatayaprot V, Glangkarn S. Verbal Screening Development of the Risk Behavior of Hepatitis B Virus among People in Community. J Health Sci. 2021;30(3):468-76. (in Thai)

Department of Disease Control (TH), Division of AIDS and STIs. National Strategy for the Prevention and Control of Hepatitis 2017-2021. Nonthaburi: Department of Disease Control; 2016. (in Thai)

Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2020.

Koo M, Yang SW. Likert-Type Scale. Encyclopedia. 2025;5(18):1-11.

Srisaard B. Principles of research. 10th ed. Mahasarakham: Mahasarakham university; 2010. (in Thai)

Boone HN, Boone DA. Analyzing Likert Data. J Ext. 2012;50:1-5.

Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.

Somsorn S. Active Communities Screening for Hepatitis B and C Virus among High-risk Populations in Lopburi Province, Fiscal Year 2024. Sci Tech Com. 2025;3(2);40-52. (in Thai)

Singharachai C, Wongwichit D, Suwanaporn S, Suttana W, Poolviwat P, Phetsuwan M, et.al. The Associated Factors of HBV and/or HCV Co-infection in Hill Tribe HIV Infection Patients in The Northern Region, Thailand, 2015. CRMJ. 2017;9(2):53-71. (in Thai)

Weldebrhan D, Berhe H, Tesfay Y. Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case-Control Study. Hepat Med.2023;15:79-91.

Evenge CNN, Menkem EZ, Ngounou E, Watching D, Erastus Nembo Nembu EN, Luma WS, et.al. Prevalence of hepatitis B and associated factors in the Buea Regional Hospital, Cameroon. Heliyon. 2023;9(7):e17745.

Ndibarema ER, Olum R, Ayebare D, Kayaking J. Prevalence and Factors Associated with Hepatitis B Infection Among Outpatient Adults in South-Western Uganda. Hepat Med. 2022; 14:163-72.

Pimsing N, Wasitthankasem R, Treesun K, Poovorawan Y, Posuwan N. Prevalence and risk factors of Hepatitis C virus in Phetchabun. DPC. 2 Phitsanulok. 2021;8(3):28-40. (in Thai)

Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol. 2014;20(40):14559-67.

Downloads

Published

2025-12-29

How to Cite

1.
Surakan P, Kabkrathok P, Leenwiphat N, Phutachai P, Nonsrirach T. Development Risk Assessment Tool for Hepatitis B and C Virus Infections for People in Health Region 7. Dis Control J [internet]. 2025 Dec. 29 [cited 2025 Dec. 31];51(4):768-82. available from: https://he01.tci-thaijo.org/index.php/DCJ/article/view/280503

Issue

Section

Original Article